It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Urogenital schistosomiasis is a neglected tropical disease caused by the parasite Schistosoma haematobium, which resides in the vasculature surrounding the urogenital system. Previous work has suggested that helminthic infections can affect the intestinal microbiome, and we hypothesized that S. haematobium infection could result in an alteration of immune system-microbiota homeostasis and impact the composition of the gut microbiota. To address this question, we compared the fecal microbiomes of infected and uninfected schoolchildren from the Argungu Local Government Area of Kebbi State, Nigeria, detecting significant differences in community composition between the two groups. Most remarkably, we observed a decreased abundance of Firmicutes and increased abundance of Proteobacteria – a shift in community structure which has been previously associated with dysbiosis. More specifically, we detected a number of changes in lower taxa reminiscent of inflammation-associated dysbiosis, including decreases in Clostridiales and increases in Moraxellaceae, Veillonellaceae, Pasteurellaceae, and Desulfovibrionaceae. Functional potential analysis also revealed an enrichment in orthologs of urease, which has been linked to dysbiosis and inflammation. Overall, our analysis indicates that S. haematobium infection is associated with perturbations in the gut microbiota and may point to microbiome disruption as an additional consequence of schistosome infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Federal University Birnin Kebbi, Department of Microbiology, Faculty of Science, Birnin Kebbi, Nigeria (GRID:grid.475123.6) (ISNI:0000 0004 6023 7915); Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia (GRID:grid.415063.5) (ISNI:0000 0004 0606 294X)
2 Brown University, Department of Molecular Microbiology and Immunology, Division of Biology and Medicine, Providence, USA (GRID:grid.40263.33) (ISNI:0000 0004 1936 9094)
3 University of Nigeria - Enugu Campus, Department of Medical Biochemistry, College of Medicine, Enugu, Nigeria (GRID:grid.10757.34) (ISNI:0000 0001 2108 8257)
4 Federal University Birnin Kebbi, Department of Microbiology, Faculty of Science, Birnin Kebbi, Nigeria (GRID:grid.475123.6) (ISNI:0000 0004 6023 7915)
5 University of Nebraska Medical Center, Division of Pediatric Infectious Diseases, Omaha, USA (GRID:grid.266813.8) (ISNI:0000 0001 0666 4105); Bayero University Kano, International Foundation Against Infectious Diseases in Nigeria, Department of Pediatrics, Kano, Nigeria (GRID:grid.411585.c) (ISNI:0000 0001 2288 989X)